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Summary
Objectives: To analyze the clinical characteristics of septic acute kidney injury (AKI) according to
the Acute Kidney Injury Network (AKIN) classification, and to evaluate the capacity of this system
in predicting in-hospital mortality of septic patients.
Methods: Patients with sepsis admitted to the infectious diseases intensive care unit (ICU) of our
hospital between January 2004 and June 2007 were retrospectively studied. Maximum AKIN stage
within the first three days of hospitalization was recorded.
Results: Three hundred fifteen patients were evaluated. According to AKIN criteria, 99 patients
(31.4%) hadAKI: 26.2%at stage1, 20.2% at stage2, and 53.6%at stage 3. Four patients (1.9%)with no
AKI progressed to stage 1, two patients (7.7%) at stage 1 progressed to stage 2, one patient (3.8%) at
stage 1 progressed to stage 3, and one patient at stage 2 (5%) progressed to stage 3. The mortality
rate was 25.3% and increased significantly from normal renal function to stage 3 (normal, 12.5%;
stage 1, 34.6%; stage 2, 45%; stage 3, 64.1%; p < 0.0001). After adjusting for age, gender, race, pre-
existing chronic kidney disease, illness severity as evaluated by acute physiology and chronic health
evaluation, version II (APACHE II) score, need formechanical ventilation, and vasopressor use, AKIN
stage 1 (odds ratio (OR) 3.03, 95% confidence interval (CI) 1.12—8.19, p = 0.029), stage 2 (OR 3.3,
95% CI 1.11—9.78, p = 0.031), and stage 3 (OR 7.35, 95% CI 3.13—17.25, p < 0.0001) predicted
mortality.
Conclusions: AKIN criteria are a useful tool to characterize and stratify septic patients according to
the risk of death.
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Until recently, multiple definitions have been used for acute
kidney injury (AKI). However, the Acute Dialysis Quality Initia-
tive (ADQI) group proposed a classification for AKI, the RIFLEPublished by Elsevier Ltd. All rights reserved.
Table 1 Classification/staging system for acute kidney injury (AKI)5 modified from RIFLE (‘risk’, ‘injury’, ‘failure’, ‘loss of kidney
function’, and ‘end-stage kidney disease’) criteria1
Stage Serum creatinine criteria Urine output criteria
1 Increase in serum creatinine of 0.3 mg/dl (26.4 mmol/l) or
increase to 150% to 200% (1.5- to 2-fold) from baseline
<0.5 ml/kg/h for more than 6 hours
2 Increase in serum creatinine to >200% to 300% (>2- to 3-fold)
from baseline
<0.5 ml/kg/h for more than 12 hours
3a Increase in serum creatinine to >300% (>3-fold) from baseline
(or serum creatinine of 4.0 mg/dl (354 mmol/l) with an acute
increase of at least 0.5 mg/dl (44 mmol/l)
<0.3 ml/kg/h for 24 hours or anuria for 12 hours
Acute kidney injury is defined as an abrupt (within 48 hours) reduction in kidney function currently defined as an absolute increase in serum
creatinine of 0.3 mg/dl (26.4 mmol/l), a percentage increase in serum creatinine of 50% (1.5-fold from baseline), or a reduction in
urine output (documented oliguria of <0.5 ml/kg per hour for more than 6 hours).
a Individuals who receive renal replacement therapy (RRT) are considered to have met the criteria of stage 3 irrespective of the stage they
are in at the time of RRT.
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stage kidney disease’) classification, in order to have auniform
standard for diagnosingand classifyingAKI.1 Some studies have
demonstrated that RIFLE predicts in-hospital mortality.2—4
Nevertheless, a more recent classification for AKI based on
RIFLE has been proposed by the Acute Kidney Injury Network
(AKIN).5 This new staging system (Table 1) differs fromRIFLE as
follows: (1) it reduces the need for a baseline creatinine but
does require at least two creatinine values within 48 hours; (2)
AKI is definedasanabrupt (within 48 hours) reduction inkidney
function currently defined as an absolute increase in serum
creatinine of 0.3 mg/dl (26.4 mmol/l), a percentage
increase in serum creatinine of50% (1.5-fold from baseline),
or a reduction in urine output (documented oliguria of
<0.5 ml/kg/h for more than 6 hours); (3) ‘risk’ maps to stage
1, but it also considers an increase in serum creatinine of
0.3 mg/dl (26.4 mmol/l); (4) ‘injury’ and ‘failure’ map to
stages 2 and 3, respectively; (5) stage 3 also includes patients
whoneed renal replacement therapy (RRT), irrespectiveof the
stage they are in at the time of RRT; and (6) the two outcome
classes ‘loss of kidney function’ and ‘end-stage kidney disease’
have been removed. These modifications could confer a
greater sensitivity and specificity to this classification, and
were based on the accumulating evidence that small increases
in serumcreatinineare associatedwith adverse outcomes, and
on the variability inherent in commencing RRTand inherent to
resources in different populations and countries.
In the present study, we sought to analyze the clinical
characteristics of septic AKI in light of the AKIN classification
and to evaluate the capacity of this system to predict in-
hospital mortality of patients with sepsis, a specific setting
where AKI is common and dramatically worsens the out-
come.6—9
Methods
This was a retrospective study including all patients with
sepsis admitted to the Infectious Diseases Intensive Care Unit
(ICU) of the Hospital de Santa Maria (Lisbon, Portugal)
between January 2004 and June 2007. This unit is the refer-
ence infectious disease unit for adult patients with infectious
diseases who need intensive care, providing medical assis-
tance to an area (Lisbon to south of Portugal) with almost
3 000 000 inhabitants.Details of septic patients and variables such as age,
gender, race, body weight, cardiovascular disease, pre-
existing chronic kidney disease, acute physiology and
chronic health evaluation, version II (APACHE II) score, need
for mechanical ventilation, vasopressor use, serum creati-
nine, urine output, RRT, and outcome were collected from
the unit database and patient medical charts. At this unit,
serum creatinine is determined at least once a day and urine
output is recorded hourly, for all patients. AKI was defined
and classified by means of the AKIN (Table 1) and RIFLE
criteria.1 Patients were categorized on serum creatinine or
urine output, or both; the criteria that led to the worst
classification were used, and the maximum AKIN and max-
imum RIFLE stage within the first three days of hospitaliza-
tion were recorded. At least two serum creatinine values
within 48 hours were considered in order to define the AKIN
stage. The diagnostic criteria were considered only after
initial fluid resuscitation to a central venous pressure of 8—
12 mmHg had been achieved (12—15 mmHg in mechanically
ventilated patients).10 Sepsis was classified in accordance
with the American College of Chest Physicians and the
Society of Critical Care Medicine consensus.11 Sepsis was
defined by the presence of both infection and a systemic
inflammatory response (SIRS — systemic inflammatory
response syndrome). SIRS was considered to be present
when patients had more than one of the following clinical
findings: body temperature >38 8C or <36 8C, heart rate
>90/min, hyperventilation evidenced by a respiratory rate
of>20/min or a PaCO2 of<32 mmHg, and a white blood cell
count of>12  109 cells/l or<4  109 cells/l. Infection was
defined as a pathologic process caused by the invasion of
normally sterile tissue or fluid or body cavity by pathogenic
or potentially pathogenic microorganisms. Severe sepsis
refers to sepsis complicated by organ dysfunction (arterial
hypoxemia defined as PaO2/FiO2 <300, acute oliguria
defined as urine output <0.5 ml/kg/h, creatinine increase
>0.5 mg/dl, coagulation abnormalities defined as interna-
tional normalized ratio (INR) >1.5 or an activated partial
thromboplastin time (aPTT) >60 s, ileus defined as absent
bowel sounds, thrombocytopenia defined as platelet count
<100  109/l, hyperbilirubinemia defined as plasma total
bilirubin >4 mg/dl or 70 mmol/l). Septic shock in adults
refers to a state of acute circulatory failure characterized
by persistent arterial hypotension unexplained by other
178 J.A. Lopes et al.causes. Hypotension was defined by a systolic arterial pres-
sure <90 mmHg, a mean arterial pressure <60 mmHg, or a
reduction in systolic blood pressure of >40 mmHg from
baseline, despite adequate volume resuscitation, in the
absence of other causes of hypotension. APACHE II was used
to evaluate illness severity, and was calculated based on the
worst variables recorded during the first 24 hours of ICU
admission.12 In-hospital mortality was considered as the
outcome measure. Complete renal recovery was considered
if the patient returned to a serum creatinine 0.2 mg/dl
above baseline serum creatinine, whereas partial renal
recovery existed if there was a persistent change in AKIN
classification (stage 1, stage 2, or stage 3) but not persistent
need for RRT. This was monitored until 60 days after hospital
admission. Chronic kidney disease patients on dialysis and
renal transplant patients were excluded from the analysis.
Since this was a retrospective and observational study that
did not evaluate a specific therapeutic or prophylactic
intervention, institutional review board ethical approval
was not required.
Statistical analysis
Continuous variables are expressed as mean  standard
deviation and categorical variables as percentage of num-
ber of cases. Comparisons between AKIN stages were per-
formed using the Chi-square test. Multivariate logistic
regression analysis was employed to determine factors
associated with mortality. The goodness of fit was tested
by means of the Hosmer—Lemeshow statistic. Collinearity
between the variables employed on the logistic regression
was tested by stepwise linear regression method. When-
ever a variance inflation factor of 10 or more occurred,
the studied variable was considered almost a perfect
linear combination of the independent variables already
in the equation and it was not added to the regression
equation. APACHE II score of 25 was employed on multi-
variate analysis because it is associated with a high risk
of death in septic patients.10 A two-tailed p value of
<0.05 was considered significant. Analysis was performed
with the statistical software package SPSS 15.0 for
Windows.Table 2 Patient baseline characteristics and renal function
Variable No AKIa N = 216 Stage 1 N = 26
Age 60 years (%) 34.7 46.1
Male (%) 61.5 69.2
Caucasian (%) 91.2 80.7
CVDb (%) 32.8 38.4
CKDc (%) 4.1 11.5
APACHE II 25d (%) 20.8 42.3
MVe (%) 38.4 53.8
Vasopressor use (%) 23.1 34.6
Mortality (%) 12.5 34.6
a AKI, acute kidney injury was defined according to the Acute Kidne
b CVD, cardiovascular disease.
c CKD, pre-existing chronic kidney disease.
d APACHE II, acute physiology and chronic health evaluation score, v
e MV, need for mechanical ventilation.Results
Baseline characteristics
During the study period, 335 patients with sepsis were
admitted to the unit, however 20 of them were chronic
kidney disease patients on dialysis and were excluded from
the analysis. None of the patients had received a renal
transplant. Therefore, 315 patients were evaluated (mean
age 53.6  18.3 years, 198 male, 282 Caucasian, mean
APACHE II score 21.2  9.09). Baseline characteristics are
summarized in Table 2.
Sepsis
One hundred and eighty-six patients (59.0%) had severe
sepsis and 106 patients (33.7%) had septic shock. In the vast
majority of cases, pulmonary (38.7%) and central nervous
system (31.4%) origin was present. Urological (9.2%) and
abdominal origin (7.3%) and endocarditis (4.1%) were present
in the remaining cases. Undetermined origin occurred in 9.3%
of patients. Microbiological analysis was positive in 66.0% of
cases, and bacteria were the most common agents (86.5%);
58.4% were Gram-positive. The remaining agents were fungi
(6.2%), viruses (5.2%), and parasites (1.9%).
Acute kidney injury
According to AKIN criteria, 99 patients (31.4%) had AKI: 26.2%
were at stage 1, 20.2% at stage 2, and 53.6% at stage 3. On the
other hand, when considering RIFLE criteria, 92 patients
(29.2%) had AKI: 23.9% were at ‘risk’, 28.2% were at ‘injury’,
and 47.9% were at ‘failure’. Despite AKIN identifying 2.2%
more patients with some degree of AKI, this difference was
not statistically significant ( p = 0.603). Patients with AKI
were older, and pre-existing chronic kidney disease was more
prevalent in such patients. Moreover, illness severity as
evaluated by APACHE II, need for mechanical ventilation,
and vasopressor use were higher in this group of patients
(Table 2). The incidence of AKI (sepsis 4.2%, severe sepsis
22.7%, septic shock 52.8%; p < 0.0001) and the percentage ofStage 2 N = 20 Stage 3 N = 53 p
35 56.6 0.034
50 69.8 0.507
85 88.6 0.480
45 45.2 0.405
20 24.5 <0.0001
55 69.8 <0.0001
70 67.9 <0.0001
55 67.9 <0.0001
45 64.1 0.001
y Injury Network classification.5
ersion II.12
Table 4 Multivariate logistic regression analysis evaluating
predictors of mortality (RIFLE class)
Variable OR 95% CI p
Age 60 years 0.78 0.39—1.57 0.490
Male 1.06 0.54—2.09 0.855
Caucasian 1.59 0.58—4.33 0.357
CVDa 0.42 0.14—1.26 0.123
APACHE II 25b 2.9 1.44—5.82 0.003
MVc 3.07 1.57—5.99 0.001
Vasopressor use 2.24 1.14—4.4 0.019
Riskd 3.39 1.18—9.73 0.023
Injuryd 3.46 1.28—9.33 0.014
Failured 9.57 3.88—23.61 <0.0001
OR, odds ratio; CI, confidence interval.
a CVD, pre-existing cardiovascular disease.
b APACHE II, acute physiology and chronic health evaluation
score, version II.12
c MV, need for mechanical ventilation.
d Classes of acute kidney injury according to RIFLE (‘risk’,
‘injury’, ‘failure’, ‘loss of kidney function’, and ‘end-stage kid-
ney disease’) classification.1
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40.5%, septic shock, 64.3%; p < 0.0001) were both higher
according to sepsis severity. In addition, the incidence of AKI
(origin: urological 48.3%, abdominal 43.5%, endocarditis
38.5%, pulmonary 36.9%, and central nervous system 10%)
and the percentage of patients with severe AKI (stage 3)
(origin: urological 71.4%, endocarditis 60%, abdominal 50%,
pulmonary 48.9%, and central nervous system 33%) both
varied according to sepsis origin. Four patients (1.9%) with
no AKI within the first three days of hospitalization pro-
gressed to stage 1, two patients (7.7%) at stage 1 progressed
to stage 2, one patient (3.8%) at stage 1 progressed to stage
3, and one patient at stage 2 (5%) progressed to stage 3. The
mean time to progress to stage 1 was 2.5 (range 1—3) days,
the time to progress from stage 1 to stage 2 was 2 days, the
time to progress from stage 1 to stage 3 was 5 days, and the
time to progress from stage 2 to stage 3 was 2 days. Twenty-
nine patients (29.3%) received RRT: 18 patients (62.1%) were
treated with continuous venovenous hemodiafiltration, eight
patients (27.6%) with intermittent hemodialysis, and the
remaining patients were treated with both modalities.
Outcome
The mortality rate was 25.3% and increased significantly as
renal function deteriorated, both evaluated by AKIN criteria
(normal renal function 12.5%, stage 1 34.6%, stage 2 45%, and
stage 3 64.1%; p < 0.0001) and by RIFLE criteria (normal renal
function 12.5%, ‘risk’ 40.9%, ‘injury’ 46.2%, and ‘failure’
68.2%; p < 0.0001). When comparing corresponding degrees
of AKI according to AKIN and RIFLE (stage 1 versus ‘risk’,
p = 0.881; stage 2 versus ‘injury’, p = 0.825; stage 3 versus
‘failure’, p = 0.840) no difference in mortality was found. In
addition, patients who developed AKI later ( p < 0.0001) or
who progressed to a more severe stage of AKI died
( p = 0.038). Moreover, mortality also increased according
to sepsis severity (sepsis 4.2%, severe sepsis 16.7%, septic
shock 45.3%; p < 0.0001), and it varied in accordance withTable 3 Multivariate logistic regression analysis evaluating
predictors of mortality (AKIN stage)
Variable OR 95% CI p
Age 60 years 0.73 0.36—1.48 0.389
Male 0.99 0.5—1.95 0.982
Caucasian 1.6 0.6—4.28 0.343
CVDa 0.42 0.14—1.28 0.13
APACHE II 25b 3.04 1.52—6.05 0.002
MVc 2.79 1.44—5.4 0.002
Vasopressor use 2.3 1.18—4.5 0.014
Stage 1d 3.03 1.12—8.19 0.029
Stage 2d 3.3 1.11—9.78 0.031
Stage 3d 7.35 3.13—17.25 <0.0001
OR, odds ratio; CI, confidence interval.
a CVD, pre-existing cardiovascular disease.
b APACHE II, acute physiology and chronic health evaluation
score, version II.12
c MV, need for mechanical ventilation.
d Stages of acute kidney injury according to the Acute Kidney
Injury Network classification.5sepsis origin (urological 37.9%, endocarditis 30.7%, abdom-
inal 30.4%, pulmonary 28.7%, and central nervous system
origin 12.1%). All patients died within the first month of
hospitalization. Among AKI patients who survived (n = 47),
the majority (n = 45, 95.7%) had complete renal function
recovery, one patient without pre-existing chronic kidney
disease who developed AKI (stage 2) had partial renal func-
tion recovery, and one patient with prior chronic kidney
insufficiency and acute deterioration of renal function (AKIN
stage 3) remained dialysis-dependent at hospital discharge.
The mean time for complete renal function recovery was
10.1  8 days (range 2—40 days). On multivariate analysis
(Tables 3 and 4), both AKIN stage (stage 1 odds ratio (OR)
3.03, 95% confidence interval (CI) 1.12—8.19, p = 0.029;
stage 2 OR 3.3, 95% CI 1.11—9.78, p = 0.031; stage 3 OR
7.35, 95% CI 3.13—17.25, p < 0.0001) and RIFLE class (‘risk’
OR 3.39, 95% CI 1.18—9.73, p = 0.023; ‘injury’ OR 3.46, 95% CI
1.28—9.33, p = 0.014; ‘failure’ OR 9.57, 95% CI 3.88—23.61,
p < 0.0001) as well as APACHE II 25, need for mechanical
ventilation, and vasopressor use were independent predic-
tors of mortality.
Discussion
Recently, the ADQI group formulated a classification, RIFLE,1
which has been shown to predict in-hospital mortality of
hospitalized patients in general and of critically ill patients in
particular.2—4 We have applied the RIFLE classification in
specific settings, namely bone marrow transplantation,13
major burn,14 critically ill HIV-infected patients,15 and
patients with sepsis,16 and have demonstrated in all these
settings that this scoring system correlates with mortality.
More recently, a new classification for AKI5 based on RIFLE
has been proposed by the Acute Kidney Injury Network
(AKIN), in order to improve sensitivity and specificity of
AKI diagnosis.
Sepsis is a well-known risk factor for the development of
AKI, and nearly half of all patients with AKI have sepsis.17,18
180 J.A. Lopes et al.Furthermore, as previously stated, AKI portends a worse
outcome in septic patients. Despite these considerations,
only a few clinical studies have focused on the presentation,
profile, and outcome of septic AKI.17—20
We conducted a retrospective study to analyze the clinical
characteristics of the septic AKI in light of the AKIN classi-
fication, and to evaluate the capacity of this system in
predicting in-hospital mortality of patients with sepsis, by
comparison with the RIFLE criteria.
We found that nearly one-third of septic patients devel-
oped AKI. In a Belgian single-center study, AKI was identified
in 16% of septic patients hospitalized in a surgical ICU.19
Conversely, in a German multicenter study, 41.4% of ICU
patients with severe sepsis and septic shock had AKI.9 Wide
variations in patient populations and definitions of AKI could
explain discrepancies in terms of AKI incidence.
We also observed that AKI developed early in the course of
sepsis with maximum renal function deterioration occurring
within the first days. Moreover, only a minority of patients
had AKI or progressed to a more severe AKI stage later. These
findings support those of previous investigations that have
revealed AKI and maximum AKI occurring early in the course
of sepsis.19
Similar to results reported in other studies,18,19 we found
that the development of AKI after a diagnosis of sepsis is
associated with older age, greater severity of illness, greater
need for mechanical ventilation, and greater need for
vasoactive support, when compared with those patients
who do not develop AKI.
The majority of AKI patients who survived had complete
renal function recovery at hospital discharge. In fact,
patients with septic AKI appear more likely to recover
renal function to RRT independence by hospital dis-
charge;18 however pathophysiologic features that may
portend an improved rate of renal recovery remain
unknown.
We showed that mortality increased according to AKI
severity, and both AKIN stages and RIFLE classes were inde-
pendently associated with mortality. The minor discrepan-
cies in odds ratios and the major degree of overlap in
confidence intervals for mortality between AKIN stages
and RIFLE classes, however, do not allow us to conclude that
AKIN criteria have a greater prognostic accuracy. This does
not preclude the AKIN from improving the overall robustness
of the RIFLE criteria in predicting the outcome of septic
patients. In fact, as this was a single center and retrospec-
tive studywith a relatively small number of patients, it is not
ideal to validate the AKIN criteria. Moreover, a relatively
high percentage of neurological infections was found,
whereas in most large sepsis studies the most common
sources of infection are pulmonary and abdominal.21 This
might be due to the pattern of reference to this unit. Despite
these limitations, our study suggests that AKIN could provide
an effective stratification of septic patients according to the
risk of death.
Finally, it is interesting that our study also found that later
development of AKI or progression to a more severe stage of
AKI in the course of disease appears to lead to a worse
outcome. This finding supports the notion that progression
of AKI has important prognostic implications,2 and AKIN, like
RIFLE, could allow for monitoring of progression of AKI in the
course of sepsis.Conclusions
AKIN criteria appear to provide a useful characterization of
septic acute kidney injury and could be an effective and
simple tool to stratify septic patients according to the risk of
death. However, prospective and multicenter studies with a
significantly larger number of patients are needed to confirm
these results.
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